InvestorsHub Logo

RMacchio

04/13/21 2:28 PM

#2842 RE: tim00mike #2841

South Korean chipmaker bats US FDA approval of its non-invasive glucose monitoring device


Drip, drip, drip... the sound of KNWN's competitive advantage eroding away.

Those who say KNWN still has time are deluding themselves. Even if KNWN has a superior product it won't make a difference if they can't get it out the door and soon.

Those who say KNWN has been slowed down because of COVID are not being honest... COVID presents challenges to all companies but it hasn't stopped those companies from making real progress.

10 months without any progress on the UBand is inexcusable. It's time for the company to provide real news on the UBand, if only to tell us that they haven't been successful in miniaturizing the technology.